Amani Alghalayini

Dr. Amani Alghalayini is a multidisciplinary Postdoctoral Research Associate at the School of Life Sciences, University of Technology Sydney (UTS). Her research spans cell biology, molecular biology, biophysics, biotechnology, and sensor development, with a focus on ARID1A-mutant ovarian clear cell carcinoma and CLIC protein therapeutic applications. She actively engages in industry collaborations with companies like Alcolizer Technology Pty Ltd, Surgical Diagnostics Pty Ltd, and BOD Sciences, and has gained national media attention for her work.

• PhD in Biology and Biotechnology from UTS (2020)
• Specializes in biosensor development, nanotechnology, and precision medicine
• Recipient of multiple awards including UTS Dean's Award and Commercialisation Award

Her research interests center on translational biomedical science, combining nano-biosensor technology and protein functional analysis to address clinical challenges in oncology and infectious diseases. Key projects include:

• Developing rapid point-of-care diagnostic platforms for viral detection
• Investigating CLIC proteins' antioxidant and ion channel activities
• Exploring drug repurposing strategies for chemoresistant cancers
• Creating novel antimicrobial agents with cholic acid and peptide mimics

Scientific contributions include:

• 15+ peer-reviewed publications in journals like Cancers, Biomolecules, and International Journal of Molecular Sciences
• Key role in developing Virulizer, an automated diagnostic device
• Leadership in industry-funded projects from Innovative Manufacturing Cooperative Research Centre and Therapeutic Innovation Australia

As a joint supervisor, she mentors students in research projects related to CLIC protein studies, exosome biomarkers, and nano-vaccine development, while teaching Cell Biology and Genetics. Her work integrates with the Faculty of Science and Women & Children’s Health Research Collaborative at UTS.